One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

We Use Cookies

We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.

BAX

BULL

2026-08-13

Overnight Institutional Flow Signal · Healthcare

See the 2026-08-13 Morning Briefing

This is one candidate from GammaRips' nightly scan of about 3,500 optionable US stocks, curated into a small high-signal pool and tracked to its outcome. Data, not a recommendation. New here? See how the pool is built → Or put your AI agent on this data →

Score

6/10

Move

2.4%

Flow

$1.3M

AI Trade Thesis

BAX BULL $27.5C Sep 18 '26. The institutional flow shows significant premium concentration in long-dated call contracts, positioning for a continuation of the post-earnings recovery catalyzed by Baxter's Q2 earnings beat, raised full-year guidance, and ongoing $500 million debt tender offer. Technically, the accumulation occurs as the underlying spot consolidates around the $26.95 level, offering a constructive entry point for a medium-term upward trend. Risk factor: Persistent margin compression in the first half of the year remains a fundamental overhang if cost headwinds do not fully resolve as projected by management.

Flow Breakdown

Call Volume

$1.2M

Put Volume

$82K

Flow Intent

DIRECTIONAL

Catalyst

Earnings Beat

More Bullish Flow · 2026-08-13

OCUL8/10 MRK7/10 ABT7/10 MRNA6/10 OMF9/10 TWLO8/10

Engine-Selected Contract

ContractO:BAX260918C00027500

Strike$27.50

Expiration2026-09-18

Contract Score7.304/10

Risk/Reward0.6:1

Delta0.45

Key Levels

Resistance$30.00

Support$21.40

Price$26.95

SMA 50 / 200$23 / $20

52W Range$16 — $32

RSI (14)63

News & Catalyst Analysis

Key Headline

Baxter Reports Second-Quarter 2026 Results, Beats Expectations and Raises Full-Year Guidance

News Summary

Baxter International is experiencing a minor short-term pullback following a substantial multi-week rally driven by a strong Q2 earnings beat, raised full-year 2026 sales and EPS guidance, and a $500 million debt tender offer. Wall Street has aggressively revised price targets upward on improved margin-recovery visibility, indicating that institutional demand is likely to persist despite the recent consolidation. The constructive long-term outlook is further supported by the company's deleveraging efforts and stable organic medical-product demand.

Flow Intent Analysis

The positioning is concentrated in far out-of-the-money long-dated call options, indicating an anticipatory bet on a continued post-earnings recovery and valuation rerating rather than a hedge against near-term equity downside.

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

Read the 2026-08-13 morning briefing for the full scan this BAX signal came from: the bull and bear split, the themes institutional money leaned into, and every other ticker that cleared the bar that day.

How We Read This Flow

Plain-English explainers on the methodology behind signals like this one.

View all →

One email a week. Catch up in five minutes.

BAX

Key Headline

News Summary

Flow Intent Analysis

One email a week. Catch up in five minutes.

How We Read This Flow

How to Read Unusual Options Activity: A Step-by-Step Guide

What Data Does an AI Trading Agent Actually Need?

How to Connect Claude to Live Options Data (MCP Setup Walkthrough)